Skip to main content
. 2017 Feb 19;8(13):21305–21314. doi: 10.18632/oncotarget.15515

Figure 3. Fluorescence-activated cell sorting analysis with markers of bone marrow mesenchymal stem cells (BMMSCs).

Figure 3

(A) We found that 97.58% of the isolated cells expressed CD29; (B) 0.69% expressed CD34; (C) 66.88% expressed CD44; (D) 2.24% expressed CD45; and (E) 63.80% expressed CD90.